A phase II study of the cancer vaccine GVAX in patients with chronic myeloid leukaemia.
Phase of Trial: Phase II
Latest Information Update: 12 Mar 2010
At a glance
- Drugs Imatinib; Tumour cell vaccine-GVAX
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 12 Mar 2010 Results reported in BioSante media release.
- 03 Jun 2006 New trial record